Clavis Pharma ASA : Appointments of Interim Chairman and Acting CEO
Oslo, Norway, 22 May 2013
Clavis Pharma ASA (OSE: CLAVIS), announces that the Board of Directors of Clavis Pharma has appointed Martin Nes, a board member of the Company, as Interim Chairman of the Board of Directors. Mr Nes replaces Anders P. Wiklund, who resigned from the Board of Directors effective 21 May 2013.
The Board has also appointed Gunnar Manum, the CFO of Clavis Pharma, to the additional position of Acting CEO, until a long-term strategic solution is found for the Company.
Chief Financial Officer
+47 24 11 09 71
+47 95 17 91 90 (mob)